Neurogene, Inc. (NGNE)
28.31
-2.94
(-9.41%)
USD |
NASDAQ |
Sep 25, 16:00
28.32
+0.01
(+0.04%)
After-Hours: 19:59
Neurogene Price : 28.31 for Sept. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | 31.31 | 31.31 | 28.23 | 28.31 | 200108.0 |
| Sep 24, 2026 | 30.85 | 31.78 | 30.43 | 31.25 | 374883.0 |
| Sep 23, 2026 | 33.49 | 33.53 | 30.09 | 30.93 | 276187.0 |
| Sep 22, 2026 | 32.94 | 34.45 | 32.79 | 33.60 | 1.223M |
| Sep 21, 2026 | 32.09 | 32.84 | 31.21 | 32.57 | 325534.0 |
| Sep 18, 2026 | 32.49 | 33.15 | 31.86 | 32.09 | 1.389M |
| Sep 17, 2026 | 35.36 | 35.64 | 32.04 | 32.41 | 171608.0 |
| Sep 16, 2026 | 34.04 | 34.86 | 33.52 | 34.67 | 232132.0 |
| Sep 15, 2026 | 35.04 | 35.04 | 33.46 | 33.69 | 147611.0 |
| Sep 14, 2026 | 35.92 | 36.28 | 34.70 | 35.21 | 194666.0 |
| Sep 11, 2026 | 36.50 | 37.64 | 35.38 | 35.48 | 181389.0 |
| Sep 10, 2026 | 37.51 | 38.25 | 36.07 | 36.12 | 177111.0 |
| Sep 09, 2026 | 38.04 | 40.42 | 37.86 | 37.88 | 193180.0 |
| Sep 08, 2026 | 37.79 | 38.75 | 36.68 | 38.13 | 228474.0 |
| Sep 04, 2026 | 37.25 | 39.38 | 36.56 | 38.60 | 205634.0 |
| Sep 03, 2026 | 38.74 | 39.19 | 36.65 | 37.61 | 255222.0 |
| Sep 02, 2026 | 37.97 | 39.78 | 36.86 | 38.36 | 252962.0 |
| Sep 01, 2026 | 35.80 | 38.21 | 35.31 | 37.87 | 134478.0 |
| Aug 31, 2026 | 36.13 | 36.64 | 35.26 | 36.24 | 120388.0 |
| Aug 28, 2026 | 37.68 | 38.56 | 36.32 | 36.58 | 132796.0 |
| Aug 27, 2026 | 38.50 | 39.81 | 37.39 | 37.86 | 149922.0 |
| Aug 26, 2026 | 40.74 | 41.77 | 38.27 | 38.41 | 180171.0 |
| Aug 25, 2026 | 40.09 | 42.01 | 39.12 | 40.84 | 504339.0 |
| Aug 24, 2026 | 38.64 | 40.82 | 37.50 | 39.64 | 439100.0 |
| Aug 21, 2026 | 38.41 | 39.44 | 37.54 | 38.63 | 346580.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.68 |
| Alnylam Pharmaceuticals, Inc. | 255.96 |
| Anika Therapeutics, Inc. | 20.37 |
| Savara, Inc. | 5.00 |
| Vericel Corp. | 39.71 |
Price Related Metrics
| PEG Ratio | -0.2731 |
| Price to Book Value | 2.064 |
| Earnings Yield | -19.44% |
| Market Cap | 448.16M |
| PEGY Ratio | -0.2731 |